A function for the lck proto-oncogene
Trends in Biochemical Sciences, ISSN: 0968-0004, Vol: 14, Issue: 10, Page: 404-407
1989
- 64Citations
- 14Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations64
- Citation Indexes64
- 64
- CrossRef39
- Captures14
- Readers14
- 14
Review Description
Proto-oncogenes encode products that comprise a select group of cellular regulatory proteins whose mutation or aberrant expression can result in oncogenic transformation. With the exception of certain growth factors and their receptors, the definition of normal functions for most proto-oncogene products has been elusive. The discovery that a member of the src-family of tyrosine protein kinases (p56lck) is associated with both the CD4 and CD8 T-lymphocyte surface glycoproteins provides the first clue to understanding the potential physiological functions of this family of proto-oncogenes.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0968000489902880; http://dx.doi.org/10.1016/0968-0004(89)90288-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0024437414&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/2683259; https://linkinghub.elsevier.com/retrieve/pii/0968000489902880; http://dx.doi.org/10.1016/0968-0004%2889%2990288-0; https://dx.doi.org/10.1016/0968-0004%2889%2990288-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know